Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial
In this exit interview analysis of adult study participants, those treated with retatrutide reported early changes in eating behavior, improved physical and emotional well-being, and weight reduction goal achievement. Some participants experienced social limitations or frustration due to adverse events or unmet expectations.
Authors
- Hayley Karn (ORCID: https://orcid.org/0009-0009-6383-9544)
- Lisa M. Neff (ORCID: https://orcid.org/0000-0002-3006-6057)
- Chisom Kanu (ORCID: https://orcid.org/0000-0002-2621-8652)
- Anastasia Hoover
- Kristina S. Boye (ORCID: https://orcid.org/0000-0002-5953-5929)
- Cecilia Jimenez‐Moreno (ORCID: https://orcid.org/0000-0002-0488-9631)
- Iris Goetz (ORCID: https://orcid.org/0000-0003-0898-9530)
- Miriam Kimel
Institutions
- Ithaka Harbors (US)
- Eli Lilly (United States) (US)
- Patient-Centered Outcomes Research Institute (US)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.obpill.2025.100220
- Citations
- 2
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.79